-
Kymera Therapeutics' (KYMR) "Buy" Rating Reiterated at Truist Financial
来源: Buzz FX / 01 11月 2024 12:02:16 America/New_York
Kymera Therapeutics' (KYMR) "Buy" Rating Reiterated at Truist Financial Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Kymera Therapeutics ( NASDAQ:KYMR - Get Free Report ) 's stock had its "buy" rating reiterated by
Read more...